Richard Smith: “This house needs new drugs”—no it doesn’t

Last week I took part in a debate at the Cambridge Union on the motion “This house needs new drugs.” The motion was proposed by the chief executive of AstraZeneca, a global pharmaceutical company that is moving its global headquarters to Cambridge and emphasising science over marketing. The Cambridge Union is designed in part to […]

Read More…

Richard Smith: Doctors and patients heading in opposite directions

Doctors and patients are heading in opposite directions: patients increasingly have multiple conditions, while doctors are specialising not just in organ systems but in parts of organs. What are the consequences of this divergence? We have known for many years now that patients have multiple conditions. As the figure from a Scottish study shows, by […]

Read More…

Richard Smith: The hypocrisy of medical journals over transparency

Medical journals generally favour transparency, but we’ve recently discovered that when there’s a trade-off between transparency and their financial interest they opt for the money. The International Committee of Medical Journals Editors, the Roman Curia of editors, wants all clinical trials to be registered and data to be shared. The BMJ is so keen on […]

Read More…

Richard Smith: Little global progress in countering non-communicable disease

In 2011 the United Nations held a high level meeting on preventing and controlling non-communicable disease (NCD) and produced a declaration on what countries should do. In 2018 it will hold another meeting to review progress, and unless there is a dramatic acceleration the meeting is likely to conclude that progress has been poor, said […]

Read More…